Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

9.82USD
19 Jul 2019
Change (% chg)

$-0.29 (-2.87%)
Prev Close
$10.11
Open
$10.13
Day's High
$10.13
Day's Low
$9.78
Volume
285,223
Avg. Vol
296,204
52-wk High
$20.85
52-wk Low
$9.51

About

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated... (more)

Overall

Beta: 2.62
Market Cap(Mil.): $863.35
Shares Outstanding(Mil.): 67.71
Dividend: --
Yield (%): --

Financials

  ALDR.OQ Industry Sector
P/E (TTM): -- 69.41 32.67
EPS (TTM): -5.14 -- --
ROI: -76.39 8.94 14.49
ROE: -76.45 10.07 15.79

Earnings vs. Estimates